- 1. Name of the medicinal product
- 2. Qualitative and quantitative composition
- 3. Pharmaceutical form
- 4. Clinical particulars
- 4.1 Therapeutic indications
- 4.2 Posology and method of administration
- 4.3 Contraindications
- 4.4 Special warnings and precautions for use
- 4.5 Interaction with other medicinal products and other forms of interaction
- 4.6 Pregnancy and lactation
- 4.7 Effects on ability to drive and use machines
- 4.8 Undesirable effects
- 4.9 Overdose
- 5. Pharmacological properties
- 5.1 Pharmacodynamic properties
- 5.2 Pharmacokinetic properties
- 5.3 Preclinical safety data
- 6. Pharmaceutical particulars
- 6.1 List of excipients
- 6.2 Incompatibilities
- 6.3 Shelf life
- 6.4 Special precautions for storage
- 6.5 Nature and contents of container
- 6.6 Special precautions for disposal and other handling
- 7. Marketing authorisation holder
- 8. Marketing authorisation number(s)
- 9. Date of first authorisation/renewal of the authorisation
- 10. Date of revision of the text
- 11. Legal category
Sodium Bicarbonate Ph.Eur.
Calcium Carbonate Ph.Eur.
Magnesium Carbonate Light Ph.Eur.
Adults, elderly and children over 12 years:Suck slowly or chew one or two tablets as required.
Children under 12 years:Not recommended.
Calcium CarbonateCalcium carbonate is converted to calcium chloride by gastric acid. Some of the calcium is absorbed from the intestines but about 85% is reconverted to insoluble calcium salts, such as the carbonate and is excreted in the faeces.
Magnesium CarbonateMagnesium carbonate reacts with gastric acid to form soluble magnesium chloride and carbon dioxide in the stomach. Some magnesium is absorbed but is usually excreted rapidly in the urine.
Sodium BicarbonateAdministration of sodium bicarbonate by mouth causes neutralisation of gastric acid with the production of carbon dioxide. Bicarbonate not involved in that reaction is absorbed and in the absence of a deficit of bicarbonate in the plasma, bicarbonate ions are excreted in the urine that is rendered alkaline with an accompanying diuresis.
Cellulose over wrapped shell and slide cardboard cartons.
|Pack sizes:||12, 30.|
250 micron UPVC /20 micron coated aluminium blister packs in cardboard cartons.
|Pack sizes:||24, 48.|
Cellophane overwrapped carton of 5 rolls of 20 tablets in wax laminated foil with paper labels.
Polypropylene roll holder with a polypropylene cap attached by a banding strip to the 100 tablet carton.
Amber glass bottle with black plastic cap.
Rolls of 20 tablets in wax laminated foil with paper label.
Polypropylene container and polypropylene lid.
|Pack sizes:||30, 50.|
Two rolls of 20 tablets in wax laminated foil packed together in cardboard carton.
Three rolls of 20 tablets in wax laminated foil packed together in cardboard carton.
Not all pack sizes may be marketed.
Forest Laboratories UK Limited (a subsidiary of Actavis PLC)
Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK
+44 (0)1271 346106
+44 (0)1271 385 200
+44(0)1271 385 257